Imaging with radiolabeled TRM-1 in patients with solid malignancies who are treated with gemcitabine, cisplatin and TRM-1.
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2009
At a glance
- Drugs Cisplatin; Gemcitabine; Mapatumumab
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Acronyms TRM-scan
- 10 Dec 2009 Planned end date (1 Mar 2010) added as reported by Netherlands Trial Register.
- 23 Nov 2009 Planned number of patients (10) and planned initiation date (22 Nov 2007) added as reported by Netherlands Trial Register.
- 23 Nov 2009 Additional lead trial centre (University Medical Center Groningen) identified as reported by Netherlands Trial Register.